about
Towards the targeted management of Chediak-Higashi syndromeApigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway[Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.[Current treatment of primary immune thrombocytopenia].An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia.Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematological abnormalities of sitosterolemia.Comparative study of three methods to detect free plasma antiplatelet antibodies.GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings.Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3.Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.Platelet receptors and signaling in the dynamics of thrombus formation.Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant.Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene.Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations.Bleeding risk of surgery and its prevention in patients with inherited platelet disordersTransient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapyBiallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia.Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors.Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients.Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause.Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype.Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia.Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.Migraine and prothrombotic genetic risk factors.Bone marrow steady-state CD34+/CD71- cell content is a predictive value of rG-CSF-mobilized CD34+ cells.Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis.Down Regulation of the Munc18b-syntaxin-11 Complex and β1-tubulin Impairs Secretion and Spreading in Neonatal Platelets.Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure.Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease.The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease.
P50
Q26829320-5845C207-62E3-4E1C-B40E-9A74EB8049B6Q28276490-93D5B344-A22E-4984-BB63-293AFC7EB3DFQ33396453-68698D21-109A-4645-8139-748306E04174Q33402393-83A0517D-7AEE-4942-99CC-B25A83932DB9Q33408719-3BD275BA-89BE-455F-B87A-A29D24BAEBC9Q33422982-7EC85F62-0D39-40B1-BC11-6FCAC40EA597Q33431635-4647D866-4E7E-464D-8393-B6ED0C8A0540Q33437105-BACC5B69-F80A-47F7-993D-101BC2C488A3Q33443549-EC258B51-F078-40FE-9418-895058573C10Q33497340-1807C9D4-44DB-4512-8C26-56341702D2A4Q33592500-2D122B16-BE00-4F49-A472-FB326911E018Q34635555-996567CA-0D23-4920-9333-5E6999AB8F85Q34996505-3C3E3FDE-81C0-4C19-A15A-2AF295FD5AC4Q35924308-573E23A8-83E5-4127-A39B-412F05CC44B5Q36024622-45D66E7E-F4C9-45BC-8FEB-FC75898B80ECQ36393452-42F58A2D-AB12-4060-8769-E2BBF1DA0114Q37175605-380BF978-2732-4EAD-B8F6-F67973D0C2FFQ37228334-C3084681-B88C-43EA-AE70-99950E264FB1Q38239378-0E813185-FB98-41D3-B777-7A9B357C9D7AQ40433186-D9A4E175-5522-4079-BD5C-72400041B620Q40681010-8846C75D-4A92-4A54-A81D-13E92A18C935Q40846341-8FD767DB-F208-4559-8ACB-54D6EBA234A9Q41480992-05819BBE-CDCD-47D2-B5C7-721F8046066EQ42315608-C3D40523-F77E-43A5-B3AE-E985AA05E1D5Q42679659-F70A2BA3-C74B-4557-8CF4-E57A1E029069Q42951363-C5412364-D4C6-4F77-A890-16370FF72936Q44997115-789887D9-66B1-4183-81CA-D6DEF6357ADCQ45861243-F8C2501E-FA45-4DB5-938A-B685085D6AC3Q46039294-45BEBE37-D9E5-4095-A759-B045E9E1E815Q46717978-3A554660-0875-4D79-9AE4-B4E1DB4F710FQ47099723-A75484E0-E5A0-465B-A811-9AEDC7A19118Q47689771-58A3FF66-8358-47B6-90B6-5814229382AAQ47804178-815CA4F5-85ED-43CD-82BB-4118494BBD79Q47956473-A07916CF-462D-419A-BA47-148736F0971EQ48005509-8E7E6BEA-824D-4084-9DBC-8774A21CB503Q50087574-DD771FE7-17FA-4333-8873-1A71949B161AQ50113632-3FE5590A-24C0-4798-8137-FBE09D206DF8Q50659089-47AF0174-2A53-4B47-B67F-E75F76837145Q50863506-21F923B5-5F3D-4D06-9E04-73F8FC452AA6Q50922979-8CDBB46C-84C1-440A-9CD9-03C39F47BAD2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria L. Lozano
@ast
Maria L. Lozano
@en
Maria L. Lozano
@es
Maria L. Lozano
@nl
Maria L. Lozano
@sl
type
label
Maria L. Lozano
@ast
Maria L. Lozano
@en
Maria L. Lozano
@es
Maria L. Lozano
@nl
Maria L. Lozano
@sl
prefLabel
Maria L. Lozano
@ast
Maria L. Lozano
@en
Maria L. Lozano
@es
Maria L. Lozano
@nl
Maria L. Lozano
@sl
P1053
J-8121-2012
P106
P1153
7102205387
P21
P31
P3829
P496
0000-0003-3148-7037